BDS INSIGHTS

The World Health Organization has an Indian doctor for its new Deputy Director General for Programmes. Dr. Soumya Swaminathan, the director general of the Indian Council of Medical Research has been appointed as the same. A paediatrician by trade, Swaminathan is famous for her research in tuberculosis. The position she now adorns in the WHO is the second highest position in the global organization. It comes only below the Director General. Dr. Tedros Adhanom Ghebreyesus, who took the post in July is the Director General. Swaminathan's is also the highest position adorned by an Indian in WHO’s history. DOCTOR RESPONSIBLE FOR RAISING INDIA’S FOCUS ON TB RESEARCH The doctor comes with over 30 years of experience in clinical research. She used to be the director of the National Institute of Research in Tuberculosis, Chennai. She has been largely responsible for heightening the focus on tuberculosis research in India. To this end, she even created a consortium called “India

Twitter Facebook LinkedIn Email Doximity Republish Print The effectiveness of the nasal spray flu vaccine illustrates of the limitations of randomized controlled trials. JOE RAEDLE/GETTY IMAGES R andomized controlled trials have long been held up as the “gold standard” of clinical research. There’s no doubt that well-designed trials are effective tools for testing a  new drug , device, or other intervention. Yet much of modern medical care — perhaps most of it — is not based on randomized controlled trials and likely never will be. In this “dark matter” of clinical medicine, past practices and anecdotes all too often rule. We need to look beyond trials to improve medical care in these areas. In a randomized controlled trial (RCT), participants are randomly assigned to receive either the treatment under investigation or, as a control, a placebo or the current standard treatment. The randomization process helps ensure that the various groups in the study

During patient treatment, the clinician needs to consider many factors that will affect the ultimate outcome. In simple terms, these factors can be grouped into 3 categories: (I) operator needs, (II) restoration needs, (III) the tooth needs. (I)The operator needs are the conditions the clinician needs to treat the tooth. (II) The restoration needs are the prep dimensions and tooth conditions for optimal strength and longevity. (III)The tooth needs are the biologic and structural limitations for a treated tooth to remain predictably functional. The Cala Lilly is a flower and is the new model for composite preparations. SOURCE: Modern Molar Endodontic Access and Directed Dentin Conservation, David Clark et al,2010

Antibiotic resistance is a result of different environmental factors and behavioral changes. Recently, antibiotic resistance has been on the rise in the past decade. In the recent turn of events, Drug Controller General of India (DCGI) has issued an urgent notice to MCI, PCI, Nursing, and Dental Council on 1st Feb 2017, about the rational use of antibiotics with the aim to limit antimicrobial resistance. Antibiotic resistance is a growing threat which needs to be contained. It has also led to the death of a patient in India. To limit the antibiotic resistance, the office has been advising about the strict requirements and prescription of Schedule H and H1 drugs for sale. Thereby, DCGI advised Indian supply chain system stakeholders for strict compliance of the Drugs & Cosmetics Act and Rules (January 2017): Taking strong policy measures, including strict regulatory action on over the counter sale of high-end antibiotics Raising awareness through different platforms and consumer